Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size

JS Bevan; SL Atkin; AB Atkinson; PM Bouloux; F Hanna; PE Harris; RA James; M McConnell; GA Roberts; MF Scanlon; Paul Stewart; E Teasdale; HE Turner; JAH Wass; JM Wardlaw

doi:10.1210/jc.2001-012012

Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size

JS Bevan, SL Atkin, AB Atkinson, PM Bouloux, F Hanna, PE Harris, RA James, M McConnell, GA Roberts, MF Scanlon, Paul Stewart, E Teasdale, HE Turner, JAH Wass, JM Wardlaw

Medical and Dental Sciences

Research output: Contribution to journal › Article

242 Citations (Scopus)

Original language	English
Pages (from-to)	4554-4563
Number of pages	10
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	87
DOIs	https://doi.org/10.1210/jc.2001-012012
Publication status	Published - 1 Oct 2002

Access to Document

10.1210/jc.2001-012012

Cite this

Bevan, JS., Atkin, SL., Atkinson, AB., Bouloux, PM., Hanna, F., Harris, PE., James, RA., McConnell, M., Roberts, GA., Scanlon, MF., Stewart, P., Teasdale, E., Turner, HE., Wass, JAH., & Wardlaw, JM. (2002). Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size. Journal of Clinical Endocrinology and Metabolism, 87, 4554-4563. https://doi.org/10.1210/jc.2001-012012

@article{8e16fe3ede75495781a8fb61df53c66f,

title = "Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size",

author = "JS Bevan and SL Atkin and AB Atkinson and PM Bouloux and F Hanna and PE Harris and RA James and M McConnell and GA Roberts and MF Scanlon and Paul Stewart and E Teasdale and HE Turner and JAH Wass and JM Wardlaw",

year = "2002",

month = oct,

day = "1",

doi = "10.1210/jc.2001-012012",

language = "English",

volume = "87",

pages = "4554--4563",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "1945-7197",

publisher = "Endocrine Society",

}

Bevan, JS, Atkin, SL, Atkinson, AB, Bouloux, PM, Hanna, F, Harris, PE, James, RA, McConnell, M, Roberts, GA, Scanlon, MF, Stewart, P, Teasdale, E, Turner, HE, Wass, JAH & Wardlaw, JM 2002, 'Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size', Journal of Clinical Endocrinology and Metabolism, vol. 87, pp. 4554-4563. https://doi.org/10.1210/jc.2001-012012

Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size. / Bevan, JS; Atkin, SL; Atkinson, AB et al.
In: Journal of Clinical Endocrinology and Metabolism, Vol. 87, 01.10.2002, p. 4554-4563.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size

AU - Bevan, JS

AU - Atkin, SL

AU - Atkinson, AB

AU - Bouloux, PM

AU - Hanna, F

AU - Harris, PE

AU - James, RA

AU - McConnell, M

AU - Roberts, GA

AU - Scanlon, MF

AU - Stewart, Paul

AU - Teasdale, E

AU - Turner, HE

AU - Wass, JAH

AU - Wardlaw, JM

PY - 2002/10/1

Y1 - 2002/10/1

UR - http://www.scopus.com/inward/record.url?scp=0036775244&partnerID=8YFLogxK

U2 - 10.1210/jc.2001-012012

DO - 10.1210/jc.2001-012012

M3 - Article

C2 - 12364434

SN - 1945-7197

VL - 87

SP - 4554

EP - 4563

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

ER -

Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE et al. Primary medical therapy for acromegaly: an open, prospective, multicentre study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-1, and tumour size. Journal of Clinical Endocrinology and Metabolism. 2002 Oct 1;87:4554-4563. doi: 10.1210/jc.2001-012012